<p>Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer</p>

Zhao Huang(Air Force Medical University), Jinbo Zhao(Air Force Medical University)

OncoTargets and Therapy

November 1, 2019

10.2147/ott.s210014

Cited by 12

Related Papers

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis

|Frontiers in Immunology|2022|54